![Figure 1. PRISMA flow diagram[39] detailing the number of studies included at each stage and the reasons for removal](https://i0.wp.com/www.drugpatentwatch.com/blog/wp-content/uploads/2018/07/Figure-1.-PRISMA-flow-diagram39-detailing-the-number-of-studies-included-at-each-stage-and-the-reasons-for-removal.jpg?fit=926%2C301&ssl=1)
Figure 1. PRISMA flow diagram[39] detailing the number of studies included at each stage and the reasons for removal Figure 1. PRISMA flow diagram[39] detailing the number of studies included at each stage and the reasons for removal
Business Intelligence on Biologic and Small Molecule Drugs